Drugs by condition
Drugs approved for low testosterone
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
21
Still marketed, NDA or BLA
Drug classes
4
Novel drugs
2
New molecular entities and new biologics
In development
0
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for low testosterone.
- Kyzatrex (Testosterone Undecanoate) · Marius Jul 27, 2022
- Tlando (Testosterone Undecanoate) · Verity Mar 28, 2022
- Jatenzo (Testosterone Undecanoate) · Tolmar Mar 27, 2019
- Xyosted (Autoinjector) (Testosterone Enanthate) · Antares Pharma INC Sep 28, 2018
- Vogelxo (Testosterone) · Upsher Smith Labs Jun 4, 2014
All approved drugs for low testosterone, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 52 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Androgen (5)
Estrogen (4)
- Premarin Estrogens, Conjugated · Wyeth Pharms · 1942
- Combipatch Estradiol, Norethindrone Acetate · Noven Pharms INC · 1998
- Estradiol Estradiol · Sandoz · 1996
- Climara Estradiol · Bayer Hlthcare · 1994
Gonadotropin (1)
- Follistim Aq Follitropin Alfa/Beta · Organon USA LLC · 2004
Class not listed in FDA's data (11)
- Parlodel Bromocriptine Mesylate · Esjay Pharma · 1978
- Kyzatrex Testosterone Undecanoate · Marius · 2022
- Tlando Testosterone Undecanoate · Verity · 2022
- Jatenzo Testosterone Undecanoate · Tolmar · 2019
- Xyosted (Autoinjector) Testosterone Enanthate · Antares Pharma INC · 2018
- Aveed Testosterone Undecanoate · Endo Operations · 2014
- Gonal-F Follitropin Alfa/Beta · Emd Serono · 1997
- Pregnyl Gonadotropin, Chorionic · Organon USA LLC · 1976
- Chorionic Gonadotropin Gonadotropin, Chorionic · Ferring · 1974
- Chorionic Gonadotropin Gonadotropin, Chorionic · Fresenius Kabi USA · 1973
- Delestrogen Estradiol Valerate · Ph Health · 1954
Drugs in development for low testosterone
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
No investigational drugs in Phase 2 or 3 trials list this condition.
1 discontinued brand-name drugs whose label still names it
- Azmiro Testosterone Cypionate
More on low testosterone: recruiting trials · published research
Related in endocrinology and women's health: Hypothyroidism · Osteoporosis · Menopause symptoms · Endometriosis · Uterine fibroids · Birth control · Growth hormone deficiency · Acromegaly · Cushing's syndrome
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.